Dr. Andrew Zolopa, MD

Low Baseline CD4+ Count Is Associated With Greater Bone Mineral Density Loss After Antiretroviral

Clinical infectious diseases, 2013

A Randomized Double-Blind Comparison of Coformulated

JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013

Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS

AIDS, 2013

Patient monitoring and follow-up in lentiviral clinical trials

JOURL OF GENE MEDICINE, 2013

Elevated Interleukin 8 and T-Helper 1 and T

JOURL OF INFECTIOUS DISEASES, 2012

When to start ART in the setting of acute AIDS-related opportunistic infections: the time is now!

Current HIV/AIDS reports, 2012

Co-formulated elvitegravir

LANCET, 2012

Standardized Comparison of the Relative Impacts of HIV-1 Reverse Transcriptase

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012

Association of Low Level Viremia with Inflammation and Mortality in HIV-Infected Adults

PLOS ONE, 2011

Blood (1 -> 3)-beta-D-Glucan as a Diagnostic Test for HIV-Related Pneumocystis jirovecii Pneumonia

CLINICAL INFECTIOUS DISEASES, 2011

Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment

AIDS, 2011

Inflammation and Mortality in HIV-Infected Adults: Alysis of the FRAM Study Cohort

JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010

Concerns Regarding a R

CLINICAL INFECTIOUS DISEASES, 2010

HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010

Early Antiretroviral Therapy for Patients With Acute AIDS-Related Opportunistic Infections

HIV CLINICAL TRIALS, 2010

Optimal antiretroviral therapy: HIV-1 treatment strategies to avoid and overcome drug resistance

CURRENT OPINION IN INVESTIGATIOL DRUGS, 2010

Risk Factor Alyses for Immune Reconstitution Inflammatory Syndrome in a R

PLOS ONE, 2010

Predicting Tipravir and Daruvir Resistance Using Genotypic, Phenotypic

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010

Intertiol Cohort Alysis of the Antiviral Activities of Zidovudine

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010

Activity of Elvitegravir, a Once-Daily Integrase Inhibitor

JOURL OF INFECTIOUS DISEASES, 2010

Development of a didanosene genotypic resistance interpretation system based on large derivation

AIDS, 2010

Association of HIV Infection

JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2010

The evolution of HIV treatment guidelines: Current state-of-the-art of ART

ANTIVIRAL RESEARCH, 2010

Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients

JOURL OF CLINICAL VIROLOGY, 2009

Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009

The use of resistance testing in the magement of HIV-1-infected patients

CURRENT OPINION IN HIV AND AIDS, 2009

Early Antiretroviral Therapy Reduces AIDS Progression

PLOS ONE, 2009

Initiation of antiretroviral therapy in the hospitalized patient with an acute AIDS

Current HIV/AIDS reports, 2009

Maintaining Reduced Viral Fitness

CLINICAL INFECTIOUS DISEASES, 2009

Hepatotoxicity and Gastrointestil Intolerance When Healthy Volunteers Taking Rifampin Add Twice

JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2009

Safety and Efficacy of Enfuvirtide in Combition with Daruvir

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008

Evaluation of high-protein supplementation in weight

AMERICAN JOURL OF CLINICAL NUTRITION, 2008

Virologic Response to Lopivir-Ritovir

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008

Initiatives for developing and comparing genotype interpretation systems

JOURL OF INFECTIOUS DISEASES, 2008

Integrase inhibitors: a clinical review of raltegravir and elvitegravir.

Jourl of HIV therapy, 2008

Effect of concomitantly administered rifampin on the pharmacokinetics

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007

Phase 2 study of the safety and efficacy of vicriviroc, a CCR5 inhibitor

JOURL OF INFECTIOUS DISEASES, 2007

A randomized, partially blinded phase 2 trial of antiretroviral therapy

JOURL OF INFECTIOUS DISEASES, 2006

N88D facilitates the co

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006

Incorporating drug-resistance measurements into the clinical magement of HIV-1 infection

JOURL OF INFECTIOUS DISEASES, 2006

The study of fat redistribution and metabolic change in HIV infection (FRAM): Methods, design

AMERICAN JOURL OF EPIDEMIOLOGY, 2006

The effect of diagnosis with HIV infection on health-related quality of life

QUALITY OF LIFE RESEARCH, 2006

Case files from Stanford University Medical Center

MedGenMed : Medscape general medicine, 2006

Pharmacokinetic interactions between indivir plus ritovir and calcium channel blockers

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005

HIV-1 protease and reverse-transcriptase mutations

JOURL OF INFECTIOUS DISEASES, 2005

Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection

CLINICAL INFECTIOUS DISEASES, 2005

Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation

CLINICAL INFECTIOUS DISEASES, 2005

Detection of minority populations of HIV

JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2005

Prevalence of antiretroviral drug resistance in the HIV-1

INTERTIOL JOURL OF STD & AIDS, 2004

Clinically validated genotype alysis: guiding principles and statistical concerns

ANTIVIRAL THERAPY, 2004

High levels of adherence do not prevent accumulation of HIV drug resistance mutations

AIDS, 2003

Lack of detectable human immunodeficiency virus type 1 superinfection during 1072 person

JOURL OF INFECTIOUS DISEASES, 2003

Extended spectrum of HIV

AIDS, 2003

Mutation patterns and structural correlates in human immunodeficiency virus type 1 protease

JOURL OF VIROLOGY, 2003

Virtual inhibitory quotient predicts response to ritovir boosting of indivir

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002

Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to

JAIDS-JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002

Evolution of primary protease inhibitor resistance mutations during protease inhibitor salvage

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002

Characterization of the HIV

JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001

HIV drug resistance testing: an update for the clinician.

AIDS clinical care, 2001

Genotypic correlates of a virologic response to stavudine after zidovudine monotherapy

JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001

Non-adherence to highly active antiretroviral therapy predicts progression to AIDS

AIDS, 2001

Phenotypic hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in treatment

AIDS, 2001

High degree of interlaboratory reproducibility of human immunodeficiency virus type 1 protease

JOURL OF CLINICAL MICROBIOLOGY, 2001

Highly active antiretroviral therapy results in HIV type 1 suppression in lymph nodes

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000

Adherence to isoniazid prophylaxis in the homeless - A randomized controlled trial

ARCHIVES OF INTERL MEDICINE, 2000

Adherence to protease inhibitors, HIV-1 viral load

AIDS, 2000

The relation between baseline HIV drug resistance and response to antiretroviral therapy

ANTIVIRAL THERAPY, 2000

Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients

JOURL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000

HIV-1 genotypic resistance patterns predict response to saquivir

ANLS OF INTERL MEDICINE, 1999

Invasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS

CLINICAL INFECTIOUS DISEASES, 1999

Clinical resistance patterns

Lawrence, J., Schapiro, J., Winters, M., Montoya, J., Zolopa, A., Pesa, 1999

Association between time homeless and perceived health status among the homeless in San Francisco

JOURL OF COMMUNITY HEALTH, 1997

PREVALENCE OF MEASLES ANTIBODIES IN ADULTS WITH HIV-INFECTION

AIDS, 1992